Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26F9AJ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,749
Award facts
- Contract value 100% obligated
- $78,748.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $78,748.82 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation. The contract, awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal contracting history with the Defense Logistics Agency demonstrates its capability to meet competitive procurement requirements for pharmaceutical products supporting military healthcare programs worldwide. This delivery order for Cosentyx, a specialty medication used in the treatment of autoimmune conditions, is consistent with the company's established role as a major vendor within the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9AJ4?
SPE2DR26F9AJ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F9AJ4 worth?
The government has obligated $78,749 on SPE2DR26F9AJ4.
Is contract SPE2DR26F9AJ4 an order under another contract?
Yes. SPE2DR26F9AJ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AJ4 competed?
The extent of competition for SPE2DR26F9AJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award